NEWPATH MANAGEMENT
Newpath Partners, LP is a life science venture firm dedicated to excellent science and to forming partnerships based on trust and a shared vision.
NEWPATH MANAGEMENT
Founded:
2018-08-15
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business
Similar Organizations
Cherrystone Angel Group
Providence based angel group interested in biopharma, medical device and tech startups in New England.
PolyCore Therapeutics
PolyCore Therapeuticsโ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Current Employees Featured
Daniel Yadegar
Daniel Yadegar CMO & Co-Founder @ Newpath Management CMO & Co-Founder 2018-09-01
Thomas Cahill
Thomas Cahill Co-Founder and Managing Partner @ Newpath Management Co-Founder and Managing Partner
Founder
Daniel Yadegar
Thomas Cahill
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-07 | Orbital Therapeutics | Newpath Management investment in Seed Round - Orbital Therapeutics | N/A |
2021-10-07 | Neumora Therapeutics | Newpath Management investment in Series A - Neumora Therapeutics | 400 M USD |
2021-10-05 | Exo Therapeutics | Newpath Management investment in Series B - Exo Therapeutics | 78 M USD |
2021-09-03 | YourBio Health | Newpath Management investment in Venture Round - YourBio Health | 21 M USD |
2021-07-13 | Prime Medicine | Newpath Management investment in Series B - Prime Medicine | 200 M USD |
2021-06-09 | Kojin Therapeutics | Newpath Management investment in Series A - Kojin Therapeutics | 60 M USD |
2021-01-06 | Myeloid Therapeutics | Newpath Management investment in Series A - Myeloid Therapeutics | 50 M USD |
2020-12-16 | Exo Therapeutics | Newpath Management investment in Series A - Exo Therapeutics | 25 M USD |
2019-10-22 | Prime Medicine | Newpath Management investment in Series A - Prime Medicine | 115 M USD |